Skip to main content
. 2018 Jan 30;7(2):CNS16. doi: 10.2217/cns-2017-0031

Figure 4. . Hazard rate and hazard ratio plots for the reanalyzed 2009 anaplastic glioma dataset.

Figure 4. 

(A) Overall survival hazard rate for 114 patients receiving eflornithine–PCV (solid line) and 114 patients receiving procarbazine, lomustine, vincristine (dashed line). (B) Shows the log hazard ratio (solid line) and 95% CI (dashed line). The Cox model fit between 0 and 2.5 years had a hazard ratio = 0.49 and p = 0.004 (see Table 2).